Sclerosing Encapsulating Peritonitis in an Anti-HCV-Positive Patient on Chronic Ambulatory Peritoneal Dialysis

Tamoxifen Therapy for Encapsulating Peritoneal Sclerosis: Mechanism of Action and Update on Clinical Experiences

“…Many reports describe tamoxifen use with concurrent glucocorticoids and further work is needed to understand the contribution that immunosuppressive agents make when added to tamoxifen. The limited side-effect profile of tamoxifen with no inherent immunosuppression activity suggests that this agent can be used in immunocompromised patients and in those with chronic or acute infections such as HIV, hepatitis C, and recent peritonitis (25,27,28).…”